Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiangzhi Qingshen Jiaonang is a Traditional Chinese Medicine (TCM) capsule formulation indicated for the treatment of hyperlipidemia and simple obesity. The product is a combination of several botanical ingredients, including *Folium Nelumbinis* (Lotus Leaf), *Fructus Crataegi* (Hawthorn), *Semen Cassiae* (Cassia Seed), and *Rhizoma Alismatis* (Alisma). Pharmacologically, the formulation is designed to lower serum cholesterol and triglycerides by inhibiting lipid absorption in the gastrointestinal tract and modulating endogenous lipid metabolism. In the context of TCM, it is used to resolve dampness, transform phlegm, and remove stasis. It is widely manufactured in China, notably by Jilin Huinan Huayi Pharmaceutical, and is typically administered orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiangzhi qingshen jiaonang.